The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria

<p>Pneumococcal conjugate vaccines (PCVs) protect against invasive pneumococcal disease (IPD) among vaccinees. However, at population level, this protection is driven by indirect effects. PCVs prevent nasopharyngeal acquisition of vaccine-serotype (VT) pneumococci, reducing onward transmission...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamu, AL, Ojal, J, Abubakar, IA, Odeyemi, KA, Bello, MM, Okoromah, CAN, Karia, B, Karani, A, Akech, D, Inem, V, Scott, JAG, Adetifa, IMO
Formato:	Journal article
Lenguaje:	English
Publicado:	Springer Nature 2023

Ejemplares similares

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Aishatu L. Adamu, et al.
Publicado: (2023-05-01)

Nasopharyngeal pneumococcal carriage in Nigeria: A two-site, population-based survey
por: Adetifa, I, et al.
Publicado: (2018)

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
por: Hammitt, LL, et al.
Publicado: (2019)

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
por: Eileen M Dunne, PhD, et al.
Publicado: (2018-12-01)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: Anna M.M. van Deursen, et al.
Publicado: (2012-11-01)

Radiographically confirmed pneumonia in Malawian children and associated pneumococcal carriage after introduction of the 13-valent pneumococcal conjugate vaccine
por: Grace Mzumara, et al.
Publicado: (2024-10-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
por: V. K. Tatochenko, et al.
Publicado: (2012-03-01)

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial
por: Egere, U, et al.
Publicado: (2012)

Nasopharyngeal pneumococcal carriage in healthy Turkish children after 13-valent conjugated pneumococcal vaccine implementation in the national immunization program
por: Saliha Kanık Yüksek, et al.
Publicado: (2020-02-01)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Edmunds W John, et al.
Publicado: (2010-04-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Kristiana Alexandrova Nikolova, et al.
Publicado: (2021-10-01)

Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage
por: Ojal, J, et al.
Publicado: (2017)

13-valent pneumococcal conjugate vaccine in Africa
por: Robert Cohen, et al.
Publicado: (2017-03-01)

Pneumococcal conjugate 7-valent vacciPNEUMOCOCCAL CONJUGATE 7-VALENT VACCINE IN CHILDREN. REGIONAL EXPERIENCEne in children. Regional experience
por: N. L. Chernaya, et al.
Publicado: (2012-02-01)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
por: James T. Peterson, et al.
Publicado: (2019-03-01)

A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine.
por: Hamaluba, M, et al.
Publicado: (2015)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
por: Ralf Rene Reinert, et al.
Publicado: (2012-06-01)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
por: George Gourzoulidis, et al.
Publicado: (2023-09-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
por: Carina Valente, et al.
Publicado: (2012-01-01)

Genetic background of Cambodian pneumococcal carriage isolates following pneumococcal conjugate vaccine 13
por: Belman, S, et al.
Publicado: (2022)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
por: Ahmet Arvas, et al.
Publicado: (2017-08-01)

Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children
por: Susanna Esposito, et al.
Publicado: (2015-01-01)

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
por: David G. McIntosh
Publicado: (2009-04-01)

INTERNATIONAL EXPERIENCE WITH 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
por: David G. McIntosh
Publicado: (2009-04-01)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.
por: Sweta M Patel, et al.
Publicado: (2022-01-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
por: N. L. Chernaya, et al.
Publicado: (2013-01-01)

Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
por: Kristiana Alexandrova Nikolova, et al.
Publicado: (2024-02-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
por: Tatiane E. Hirose, et al.
Publicado: (2015-03-01)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
por: Tatiane E. Hirose, et al.
Publicado: (2015-03-01)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
por: Sweta M. Patel, et al.
Publicado: (2022-01-01)

Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
por: Paul Turner, et al.
Publicado: (2015-11-01)

Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trialResearch in context
por: Heidi Smith-Vaughan, et al.
Publicado: (2023-03-01)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
por: Hye-Young Kim, et al.
Publicado: (2021-03-01)

Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia
por: Claire von Mollendorf, et al.
Publicado: (2024-08-01)

Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial.
por: Laura L Hammitt, et al.
Publicado: (2014-01-01)

RECOMMENDATION ON THE 7–VALENT PNEUMOCOCCAL CONJUGATED VACCINE AMONG CHILDREN
por: M.V. Fedoseenko, et al.
Publicado: (2009-06-01)

RECOMMENDATION ON THE 7–VALENT PNEUMOCOCCAL CONJUGATED VACCINE AMONG CHILDREN
por: M.V. Fedoseenko, et al.
Publicado: (2009-06-01)

Invasive pneumococcal infection despite 7-valent conjugated vaccine
por: Sebastien Joye, et al.
Publicado: (2013-03-01)

The Burden of Pneumococcal Disease in the Canadian Population Before Routine Use of the Seven-Valent Pneumococcal Conjugate Vaccine
por: Adrienne Morrow, et al.
Publicado: (2007-01-01)

Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules
por: Hong-Yi Lee, et al.
Publicado: (2018-04-01)